TITLE:
An Investigational Agent for the Treatment of Complicated Intra-Abdominal Infections or Acute Pelvic Infections (0826-038)

CONDITION:
Infections

INTERVENTION:
MK0826, ertapenem sodium

SUMMARY:

      The purpose of this study is to determine the effect of an approved medication for adults
      for an investigational use in pediatric patients 3 months to 17 years for the treatment of
      complicated intra-abdominal infections or acute pelvic infections.
    

DETAILED DESCRIPTION:

      The duration of treatment is 18 months.
    

ELIGIBILITY:
Gender: All
Age: 3 Months to 17 Years
Criteria:

        Inclusion Criteria:

          -  Patients aged 3 months to 17 years with intra-abdominal infection or acute pelvic
             infection

        Exclusion Criteria:

          -  Immune problems

          -  Kidney problems
      
